Abstract
Expression profiles of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR), apolipoprotein E (ApoE) and cholesterol 24S-hydroxylase (CYP46), proteins involved in cholesterol biosynthesis, transport and excretion from the CNS, were analyzed in the rat cortex, hippocampus and cerebellum as a function of aging (6–24 months) and in response to long-term dietary restriction (DR). Age-related increases for all three mRNAs were observed, with the highest induction found for Cyp46 in the cortex and hippocampus of 24-month-old animals. DR maintained stable levels of Cyp46, HMGR, and ApoE mRNAs during aging, exhibiting an attenuating effect on age-related changes through specific temporal and regional pattern. Neither age nor DR had any prominent effects at the protein level, except for Cyp46 and ApoE protein levels in the hippocampus and cerebellum, respectively. Overall, the changes in the cerebellum were different from those in the cortex and hippocampus. Our results demonstrated a modulatory effect of DR on age-related changes of CYP46, HMGR, and ApoE and suggest that the anti-aging effect of DR is in part mediated though transcriptional modulation of cholesterol metabolism genes in the rat brain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beffert U, Cohn JS, Petit-Turcotte C et al (1999) Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer’s disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res 843:87–94. doi:10.1016/S0006-8993(99)01894-6
Björkhem I, Lütjohann D, Diczfalusy U et al (1998) Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 39:1594–1600
Bogdanovic N, Bretillon L, Lund EG et al (2001) On the turnover of brain cholesterol in patients with Alzheimer’s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci Lett 314:45–48. doi:10.1016/S0304-3940(01)02277-7
Boyles JK, Pitas RE, Wilson E et al (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501–1513. doi:10.1172/JCI112130
Bretillon L, Siden A, Wahlund LO et al (2000) Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett 293:87–90. doi:10.1016/S0304-3940(00)01466-X
David JP, Ghozali F, Fallet-Bianco C et al (1997) Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci Lett 235:53–56. doi:10.1016/S0304-3940(97)00708-8
Dekroon RM, Armati PJ (2001) Synthesis and processing of apolipoprotein E in human brain cultures. Glia 33:298–305. doi:10.1002/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N
Dietschy JM, Kita T, Suckling KE et al (1983) Holesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors. J Lipid Res 24:469–480
Du Y, Chen X, Wei X et al (2005) NF-(kappa)B mediates amyloid beta peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells. Brain Res Mol Brain Res 20:177–188. doi:10.1016/j.molbrainres.2005.02.001
Gardner RG, Hampton RY (1999) A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes. J Biol Chem 274:31671–31678. doi:10.1074/jbc.274.44.31671
Gee JR, Ding Q, Keller JN (2006) Age-related alterations of apolipoprotein E and interleukin-1beta in the aging brain. Biogerontology 7:69–79. doi:10.1007/s10522-005-6039-9
Han SH, Einstein G, Weisgraber KH et al (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 5:535–544. doi:10.1097/00005072-199409000-00013
Irizarry MC, Deng A, Lleo A et al (2004) Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. J Neurochem 90:1132–1143. doi:10.1111/j.1471-4159.2004.02581.x
Jiang CH, Tsien JZ, Schultz PG, Hu Y (2001) The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci USA 98:1930–1934. doi:10.1073/pnas.98.4.1930
Lahiri DK, Sambamurti K, Bennett DA (2004) Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease. Neurobiol Aging 25:651–660. doi:10.1016/j.neurobiolaging.2003.12.024
Lee CK, Weindruch R, Prolla TA (2000) Gene-expression profile of the ageing brain in mice. Nat Genet 25:294–297. doi:10.1038/77046
Leoni V, Masterman T, Diczfalusy U et al (2002) Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis. Neurosci Lett 331:163–166. doi:10.1016/S0304-3940(02)00887-X
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408
Lund EG, Guileyardo JM, Russell DW (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 96:7238–7243. doi:10.1073/pnas.96.13.7238
Lund EG, Xie C, Kotti T et al (2003) Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem 278:22980–22988. doi:10.1074/jbc.M303415200
Lütjohann D, Breuer O, Ahlborg G et al (1996) Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci USA 93:9799–9804. doi:10.1073/pnas.93.18.9799
Lütjohann D, Papassotiropoulos A, Bjorkhem I et al (2000) Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 41:195–198
Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507–537. doi:10.1146/annurev.genom.1.1.507
Martin B, Pearson M, Kebejian L et al (2007) Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excess. Endocrinology 9:4318–4333. doi:10.1210/en.2007-0161
Martin B, Pearson M, Brenneman R et al (2009) Gonadal transcriptome alterations in response to dietary energy intake: sensing the reproductive environment. PLoS ONE 1:e4146. doi:10.1371/journal.pone.0004146
Masliah E, Mallory M, Ge N et al (1995) Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 136:107–122. doi:10.1006/exnr.1995.1088
Masliah E, Samuel W, Veinbergs I et al (1997) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res 751:307–314. doi:10.1016/S0006-8993(96)01420-5
Masoro EJ (2006) Caloric restriction and aging: controversial issues. J Gerontol A Biol Sci Med Sci 61:14–19
Mattson MP (2008) Hormesis and disease resistance: activation of cellular stress response pathways. Hum Exp Toxicol 27:155–162. doi:10.1177/0960327107083417
Meaney S, Lütjohann D, Diczfalusy U, Björkhem I (2000) Formation of oxysterols from different pools of cholesterol as studied by stable isotope technique: cerebral origin of most circulating 24S-hydroxycholesterol in rats, but not in mice. Biochim Biophys Acta 1486:293–298
Metzger RE, LaDu MJ, Pan JB et al (1996) Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer’s disease. J Neuropathol Exp Neurol 55:372–380. doi:10.1097/00005072-199603000-00013
Mladenovic A, Perovic M, Tanic N et al (2007) Dietary restriction modulates alpha-synuclein expression in the aging rat cortex and hippocampus. Synapse 61:790–794. doi:10.1002/syn.20427
Morgan TE, Xie Z, Goldsmith S et al (1999) The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience 89:687–699. doi:10.1016/S0306-4522(98)00334-0
Mulas MF, Demuro G, Mulas C et al (2005) Dietary restriction counteracts age-related changes in cholesterol metabolism in the rat. Mech Ageing Dev 126:648–654. doi:10.1016/j.mad.2004.11.010
Nelson PT, Keller JN (2007) RNA in brain disease: no longer just “the messenger in the middle”. J Neuropathol Exp Neurol 66:461–468. doi:10.1097/01.jnen.0000240474.27791.f3
Ohyama Y, Meaney S, Heverin M et al (2006) Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J Biol Chem 281:3810–3820. doi:10.1074/jbc.M505179200
Okamoto K, Kakuma T, Fukuchi S et al (2006) Sterol regulatory element binding protein (SREBP)-1 expression in brain is affected by age but not by hormones or metabolic changes. Brain Res 1081:19–27. doi:10.1016/j.brainres.2006.01.081
Ong WY, Hu CY, Soh YP et al (2000) Neuronal localization of sterol regulatory element binding protein-1 in the rodent and primate brain: a light and electron microscopic immunocytochemical study. Neuroscience 97:143–153. doi:10.1016/S0306-4522(00)00031-2
Papassotiropoulos A, Lütjohann D, Bagli M et al (2000) Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer’s disease. NeuroReport 11:1959–1962. doi:10.1097/00001756-200006260-00030
Park SK, Prolla TA (2005) Lessons learned from gene expression profile studies of aging and caloric restriction. Ageing Res Rev 4:55–65. doi:10.1016/j.arr.2004.09.003
Petanceska SS, DeRosa S, Sharma A et al (2003) Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol. J Mol Neurosci 20:395–406. doi:10.1385/JMN:20:3:395
Pirttilä T, Soininen H, Heinonen O et al (1996) Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls. Brain Res 722:71–77. doi:10.1016/0006-8993(96)00183-7
Poirier J (2003) Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer’s disease. Trends Mol Med 9:94–101. doi:10.1016/S1471-4914(03)00007-8
Poirier J, Sevigny P (1999) Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer’s disease. J Psychiatry Neurosci 24:147–153
Poirier J, Baccichet A, Dea D, Gauthier S (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55:81–90. doi:10.1016/0306-4522(93)90456-P
Posse de Chaves EI, Rusiñol AE, Vance DE et al (1997) Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J Biol Chem 272:30766–30773. doi:10.1074/jbc.272.49.30766
Posse De Chaves EI, Vance DE, Campenot RB et al (2000) Uptake of lipoproteins for axonal growth of sympathetic neurons. J Biol Chem 275:19883–19890. doi:10.1074/jbc.275.26.19883
Prolla TA (2002) DNA microarray analysis of the aging brain. Chem Senses 27:299–306. doi:10.1093/chemse/27.3.299
Ramirez DM, Andersson S, Russell DW (2008) Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol 507:1676–1693. doi:10.1002/cne.21605
Reynolds GA, Basu SK, Osborne TF et al (1984) HMG CoA reductase: a negatively regulated gene with unusual promoter and 5′ untranslated regions. Cell 38:275–285. doi:10.1016/0092-8674(84)90549-X
Rowe WB, Blalock EM, Chen KC et al (2007) Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 27:3098–3110. doi:10.1523/JNEUROSCI.4163-06.2007
Stone DJ, Rozovsky I, Morgan TE et al (1997) Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol 143:313–318. doi:10.1006/exnr.1996.6360
Struble RG, Rosario ER, Kircher ML et al (2003) Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17 beta estradiol. Exp Neurol 183:638–644. doi:10.1016/S0014-4886(03)00215-2
Tanic N, Perovic M, Mladenovic A et al (2007) Effects of aging, dietary restriction and glucocorticoid treatment on housekeeping gene expression in rat cortex and hippocampus-evaluation by real time RT-PCR. J Mol Neurosci 32:38–46. doi:10.1007/s12031-007-0006-7
Terao A, Apte-Deshpande A, Dousman L et al (2002) Immune response gene expression increases in the aging murine hippocampus. J Neuroimmunol 132:99–112. doi:10.1016/S0165-5728(02)00317-X
Van Liew JB, Davis PJ, Davis FB et al (1993) Effects of aging, diet, and sex on plasma glucose, fructosamine, and lipid concentrations in barrier-raised Fischer 344 rats. J Gerontol 5:B184–B190
Vance JE, Karten B, Hayashi H (2006) Lipid dynamics in neurons. Biochem Soc Trans 34:399–403. doi:10.1042/BST0340399
Wechsler A, Brafman A, Shafir M et al (2003) Generation of viable cholesterol-free mice. Science 302:2087. doi:10.1126/science.1090776
Xu PT, Gilbert JR, Qiu HL et al (1998) Regionally specific neuronal expression of human APOE gene in transgenic mice. Neurosci Lett 246:65–68. doi:10.1016/S0304-3940(98)00247-X
Xu PT, Gilbert JR, Qiu HL et al (1999) Specific regional transcription of apolipoprotein E in human brain neurons. Am J Pathol 154:601–611
Acknowledgments
We thank Dr. Suzana Petanceska (Nathan Kline Institute, NY, USA) for providing the anti-Cyp46 antibodies. This work was supported by the Ministry of Science and Technological Development, Republic of Serbia, grant # 143 004.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors Milka Perovic and Aleksandra Mladenovic Djordjevic equally contributed to this article.
Rights and permissions
About this article
Cite this article
Perovic, M., Mladenovic Djordjevic, A., Smiljanic, K. et al. Expression of cholesterol homeostasis genes in the brain of the male rat is affected by age and dietary restriction. Biogerontology 10, 735–745 (2009). https://doi.org/10.1007/s10522-009-9220-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-009-9220-8